Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atricure Inc (NQ: ATRC )

21.75 -0.35 (-1.58%)
Streaming Delayed Price Updated: 11:27 AM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Atricure Inc

< Previous 1 2 Next >
AtriCure Reports Third Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Third Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Announces Investor Education Webcast with Hybrid AF Therapy Key Opinion Leaders
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Second Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate at Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Second Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
From AtriCure, Inc.
Via Business Wire
AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer
From AtriCure, Inc.
Via Business Wire
AtriCure Reports First Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce First Quarter 2022 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Publishes Inaugural ESG Report
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Third Quarter 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Third Quarter 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Second Quarter 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate at the Canaccord 41st Annual Growth Conference
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Second Quarter 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Names Two New Members to the Board of Directors
From AtriCure, Inc.
Via Business Wire
AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
From AtriCure, Inc.
Via Business Wire
AtriCure Reports First Quarter 2021 Financial Results
From AtriCure, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.